MA28354A1 - Nouvelles combinaisons d'un agent anti-emetique et d'un inhibiteur de l'enkephalinase - Google Patents

Nouvelles combinaisons d'un agent anti-emetique et d'un inhibiteur de l'enkephalinase

Info

Publication number: MA28354A1
Authority: MA; Morocco
Prior art keywords: emetic agent; novel combinations; enkephalinase inhibitor; combinations; enkephalinase
Prior art date: 2004-02-12

Application number

MA29256A

Other languages

English (en)

Inventor

Jean-Charles Schwartz

Jeanne-Marie Lecomte

Original Assignee

Bioprojet Soc Civ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-12

Filing date

2006-08-10

Publication date

2006-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28354(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-08-10 Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ

2006-12-01 Publication of MA28354A1 publication Critical patent/MA28354A1/fr

Links

229940122586 Enkephalinase inhibitor Drugs 0.000 title abstract 2
239000002111 antiemetic agent Substances 0.000 title abstract 2
229940125683 antiemetic agent Drugs 0.000 title abstract 2
239000002792 enkephalinase inhibitor Substances 0.000 title abstract 2
206010012735 Diarrhoea Diseases 0.000 abstract 1
208000005577 Gastroenteritis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

MA29256A 2004-02-12 2006-08-10 Nouvelles combinaisons d'un agent anti-emetique et d'un inhibiteur de l'enkephalinase MA28354A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04290384A EP1563848A1 (fr)	2004-02-12	2004-02-12	Nouvelles combinaisons d' agents antiémétiques avec inhibiteurs de l'enképhalinase

Publications (1)

Publication Number	Publication Date
MA28354A1 true MA28354A1 (fr)	2006-12-01

Family

ID=34684783

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29256A MA28354A1 (fr)	2004-02-12	2006-08-10	Nouvelles combinaisons d'un agent anti-emetique et d'un inhibiteur de l'enkephalinase

Country Status (28)

Country	Link
US (1)	US8222294B2 (fr)
EP (2)	EP1563848A1 (fr)
JP (1)	JP4987487B2 (fr)
KR (1)	KR101152308B1 (fr)
CN (1)	CN1917903B (fr)
AT (1)	ATE468138T1 (fr)
AU (1)	AU2005215262B2 (fr)
BR (1)	BRPI0506631B8 (fr)
CA (1)	CA2553827C (fr)
CY (1)	CY1110202T1 (fr)
DE (1)	DE602005021317D1 (fr)
DK (1)	DK1718337T3 (fr)
EA (1)	EA010625B1 (fr)
EC (1)	ECSP066758A (fr)
ES (1)	ES2344909T3 (fr)
HR (1)	HRP20100363T1 (fr)
MA (1)	MA28354A1 (fr)
ME (1)	ME01175B (fr)
NO (1)	NO337320B1 (fr)
NZ (1)	NZ548635A (fr)
PL (1)	PL1718337T3 (fr)
PT (1)	PT1718337E (fr)
RS (1)	RS51329B (fr)
SI (1)	SI1718337T1 (fr)
TN (1)	TNSN06246A1 (fr)
UA (1)	UA88156C2 (fr)
WO (1)	WO2005079850A1 (fr)
ZA (1)	ZA200605872B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2900823B1 (fr) *	2006-05-15	2009-02-13	Bioprojet Soc Civ Ile	Nouvelle forme d'administration du racecadotril.
EP2462922A1 (fr) *	2010-12-10	2012-06-13	Bioprojet	Nouvelle forme d'administration pour inhibiteurs de l'enképhalinase
EP2866802B1 (fr) *	2012-06-28	2016-07-27	Johnson & Johnson Consumer Inc.	Compositions liquides de racécadotril
US9801819B2 (en) *	2012-06-28	2017-10-31	Johnson & Johnson Consumer Inc.	Racecadotril compositions
RU2632441C2 (ru)	2012-06-28	2017-10-04	МакНЕЙЛ-ППС, ИНК.	Липидные композиции рацекадотрила
US9114171B2 (en) *	2012-06-28	2015-08-25	Mcneil-Ppc, Inc.	Racecadotril liquid compositions
MA40859A (fr)	2014-10-29	2017-09-05	Johnson & Johnson Consumer Inc	Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0028575D0 (en) *	2000-11-23	2001-01-10	Elan Corp Plc	Oral pharmaceutical compositions containing cyclodextrins

2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/fr not_active Withdrawn
2005
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/fr unknown
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 EP EP05702484A patent/EP1718337B1/fr not_active Expired - Lifetime
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/fr not_active Ceased
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de not_active Expired - Lifetime
- 2005-02-14 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 US US10/587,899 patent/US8222294B2/en not_active Expired - Fee Related
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es not_active Expired - Lifetime
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko not_active Expired - Fee Related
- 2005-02-14 CA CA2553827A patent/CA2553827C/fr not_active Expired - Fee Related
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/sr unknown
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
2010
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown

Also Published As

Publication number	Publication date
NO20063973L (no)	2006-09-05
EP1563848A1 (fr)	2005-08-17
CN1917903B (zh)	2010-07-21
PT1718337E (pt)	2010-06-16
CA2553827A1 (fr)	2005-09-01
AU2005215262B2 (en)	2011-03-03
PL1718337T3 (pl)	2010-09-30
NO337320B1 (no)	2016-03-07
WO2005079850A1 (fr)	2005-09-01
BRPI0506631B8 (pt)	2021-05-25
JP2007522202A (ja)	2007-08-09
RS51329B (sr)	2011-02-28
BRPI0506631A (pt)	2007-05-08
ATE468138T1 (de)	2010-06-15
BRPI0506631B1 (pt)	2018-12-04
NZ548635A (en)	2009-10-30
UA88156C2 (ru)	2009-09-25
TNSN06246A1 (fr)	2007-12-03
HRP20100363T1 (hr)	2010-07-31
CA2553827C (fr)	2012-08-07
EP1718337A1 (fr)	2006-11-08
ECSP066758A (es)	2006-11-24
US8222294B2 (en)	2012-07-17
DE602005021317D1 (de)	2010-07-01
KR101152308B1 (ko)	2012-06-11
DK1718337T3 (da)	2010-07-26
ES2344909T3 (es)	2010-09-09
EA010625B1 (ru)	2008-10-30
SI1718337T1 (sl)	2010-08-31
EA200601466A1 (ru)	2006-12-29
EP1718337B1 (fr)	2010-05-19
ME01175B (fr)	2013-03-20
CN1917903A (zh)	2007-02-21
JP4987487B2 (ja)	2012-07-25
CY1110202T1 (el)	2015-01-14
KR20060132691A (ko)	2006-12-21
US20070275993A1 (en)	2007-11-29
ZA200605872B (en)	2008-01-08
AU2005215262A1 (en)	2005-09-01

Publication	Publication Date	Title
ATE448303T1 (de)	2009-11-15	Vektoren zur gerichteten klonierung
ATE348616T1 (de)	2007-01-15	2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de)	2007-02-15	3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
NO20063624L (no)	2006-10-03	FC region varianter
DK1836201T3 (da)	2010-12-06	Pyrrolidininhibitorer af IAP
DE602004019812D1 (de)	2009-04-16	Marker für neuromyelitis optica
EA200301100A1 (ru)	2004-06-24	Новые фталазиноны
ATE304858T1 (de)	2005-10-15	Mischung enthaltend einen inhibitor oder suppressor eines gens und ein molekül,dass an ein expressionprodukt dieses gens bindet
CY1110202T1 (el)	2015-01-14	Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης
MXPA04003755A (es)	2004-07-23	Endoprotesis vasculares.
UY28344A1 (es)	2005-01-31	Nuevos compuestos
NO20062062L (no)	2006-07-24	Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat
DK1377574T3 (da)	2005-04-25	6-phenylbenzonaphtyridiner
FI20031191A7 (fi)	2003-08-25	Monoamiinin takaisinoton estäjä
EA200500878A1 (ru)	2005-10-27	Кальцилитические соединения
HU0201394D0 (fr)	2002-06-29
DK1390364T3 (da)	2004-12-20	Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
DE50212676D1 (de)	2008-10-02	Exopolysaccharidproduktion
DE602004012356D1 (de)	2008-04-24	Pyrrolpolymerzusammensetzungen
ATE360021T1 (de)	2007-05-15	Neue benzonaphthyridine
MA25710A1 (fr)	2003-04-01	Composition de marquage anticopie.
DOP2001000275A (es)	2002-05-30	Inhibidores de metaloproteinasa del tipo pirmidin-2,4,6-triona.
UA5522S (uk)	2001-12-17	Танкова гармата калібру 120 мм.